Prestige Consumer Healthcare Inc. PBH
1 trading plan running, 8 Form 144 notices for $424K
10-Q, 10-K and Form 144What PBH's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Sep 15, 2023 to Aug 27, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired.
| Insider | What | Date | Reported in | ||
|---|---|---|---|---|---|
| Jeffrey Zerillo Senior Vice President Operations |
Adopted 10b5-1 plan | Jun 11, 2026 | 10-Q Aug 6, 2026 | ||
What the company wroteName and Position Date of Signature Effective Date Action Satisfies Affirmative Defense under Rule 10b5-1(c) Expiration Date Total Ordinary Shares to be Sold Jeffrey Zerillo June 11, 2026 October 1, 2026 Adoption X August 27, 2027 10,444 Senior Vice President Operations | |||||
| Jeffrey Zerillo Senior Vice President Operations |
Adopted 10b5-1 plan | Aug 26, 2025 | 10-Q Nov 6, 2025 | ||
What the company wroteName and Position Date Action Satisfies Affirmative Defense under Rule 10b5-1(c) Expiration Date Total Ordinary Shares to be Sold Jeffrey Zerillo August 26, 2025 Adoption X September 30, 2026 12,594 Senior Vice President Operations | |||||
| Mary Beth Fritz Senior Vice PresidentQuality & Regulatory Affairs |
Adopted 10b5-1 plan | Dec 2, 2024 | 10-Q Feb 6, 2025 | ||
What the company wroteThe following is a summary of the material terms of the contracts, instructions or written plans for the purchase or sale of the Company's securities adopted or terminated by our officers (as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended) or directors during the three months ended December 31, 2024: Name and Position Date Action Satisfies Affirmative Defense under Rule 10b5-(c) Expiration Date Total Ordinary Shares to be Sold Mary Beth Fritz December 2, 2024 Adoption X June 30, 2025 10,713 Senior Vice President Quality & Regulatory Affairs | |||||
| Mary Beth Fritz Senior Vice President |
Adopted 10b5-1 plan | Sep 15, 2023 | 10-Q Nov 2, 2023 | ||
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 5, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| May 11, 2026 | Zerillo Jeffrey Officer |
351 | $18K |
| May 7, 2026 | Zerillo Jeffrey Officer |
305 | $17K |
| May 6, 2026 | Zerillo Jeffrey Officer |
1,207 | $66K |
| May 5, 2026 | Zerillo Jeffrey Officer |
346 | $19K |
| Feb 11, 2026 | Zerillo Jeffrey Officer |
1,000 | $66K |
| Dec 1, 2025 | Zerillo Jeffrey Officer |
281 | $17K |
| Nov 28, 2025 | Zerillo Jeffrey Officer |
719 | $43K |
| Nov 25, 2025 | BYOM JOHN E Director |
3,000 | $178K |
From the Form 144 XML filed with the SEC, since Nov 25, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/PBH/export.csv") into a cell.